Vir Biotechnology, Inc. (VIR)
10.29
+0.28
(+2.80%)
USD |
NASDAQ |
May 06, 16:00
10.27
-0.02
(-0.19%)
After-Hours: 20:00
Vir Biotechnology Cash from Investing (Quarterly) : 86.65M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | -83.68M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Gossamer Bio, Inc. | 73.16M |
| Sensei Biotherapeutics, Inc. | 1.743M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.88M |
| Cash from Financing (Quarterly) | 1.039M |
| Free Cash Flow | -396.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1883 |
| Free Cash Flow to Equity (Quarterly) | -23.90M |
| Free Cash Flow to Firm (Quarterly) | -26.22M |
| Free Cash Flow Yield | -27.83% |